Imricor Medical Systems, Inc. Share Price

Equities

IMR

AU0000054942

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 10:27:01 26/04/2024 am IST 5-day change 1st Jan Change
0.49 AUD -2.00% Intraday chart for Imricor Medical Systems, Inc. -4.85% -14.04%

Financials

Sales 2024 * 3.81M 5.83M 318M Sales 2025 * 8.74M 13.38M 729M Capitalization 64.73M 99.09M 5.4B
Net income 2024 * -14M -21.43M -1.17B Net income 2025 * -11M -16.84M -917M EV / Sales 2024 * 13.9 x
Net cash position 2024 * 11.7M 17.91M 976M Net cash position 2025 * 13.7M 20.97M 1.14B EV / Sales 2025 * 5.84 x
P/E ratio 2024 *
-4.84 x
P/E ratio 2025 *
-6.27 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 62.1%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Imricor Medical Systems, Inc.

1 day-2.00%
1 week-4.85%
Current month-12.50%
1 month-13.27%
3 months-19.01%
6 months-14.78%
Current year-14.04%
More quotes
1 week
0.48
Extreme 0.48
0.52
1 month
0.48
Extreme 0.48
0.60
Current year
0.42
Extreme 0.42
0.63
1 year
0.26
Extreme 0.26
0.84
3 years
0.11
Extreme 0.105
2.10
5 years
0.11
Extreme 0.105
2.94
10 years
0.11
Extreme 0.105
2.94
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 01/06/01
Director of Finance/CFO - 01/20/01
Chief Tech/Sci/R&D Officer - 01/20/01
Members of the board TitleAgeSince
Director/Board Member - 01/21/01
Director/Board Member 58 01/19/01
Director/Board Member 57 01/14/01
More insiders
Date Price Change Volume
26/24/26 0.49 -2.00% 55,367
24/24/24 0.5 +4.17% 61,146
23/24/23 0.48 -7.69% 27,606
22/24/22 0.52 +0.97% 33,555
19/24/19 0.515 +1.98% 83,724

Delayed Quote Australian S.E., April 26, 2024 at 10:27 am IST

More quotes
Imricor Medical Systems, Inc. is a developer of magnetic resonance imaging (MRI)-compatible medical devices, which is used to carry out real-time interventional Cardiac Magnetic Resonance Imaging (iCMR) cardiac ablation procedures. The Company is engaged in designing, manufacturing, and selling MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. Its products include Vision-mitral regurgitation (MR) Ablation Catheter, Advantage-MR electrophysiology (EP) Recorder/Stimulator and Vision-MR Dispersive Electrode. The Vision-MR Ablation Catheter is designed to work under real-time MRI guidance. Advantage-MR EP Recorder/Stimulator System provides technology that allows physicians to utilize both the EP recording system and a cardiac stimulator while ablating within the iCMR environment. The Company sells its products to hospitals and clinics for use in iCMR labs, in which ablation procedures using the Vision-MR Ablation Catheter can be performed.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.3196 USD
Average target price
0.616 USD
Spread / Average Target
+92.77%
Consensus

Annual profits - Rate of surprise